Status
INACTIVE
Global HQ
San Sebastian, Spain
Countries of investment
- Spain
- Portugal
- France
- Germany
- Israel
- United States
Investment stages
- Seed
- Series A
Industries
- Deeptech
- Life Sciences
- Digital Tech
- Venture Debt
- Industrial Tech
About
Inveready is one of Spain's leading alternative asset managers backing innovative companies across their entire lifecycle. Their focus spans digital technologies, life sciences, venture debt, infrastructure, and public market strategies. The firm combines €1.2B+ AUM across 35+ funds with offices in San Sebastián, Barcelona, and Madrid to support founders from seed through public listings.
Inveready is one of Spain's leading alternative asset managers backing innovative companies across their entire lifecycle. Their focus spans digital technologies, life sciences, venture debt, infrastructure, and public market strategies. The firm combines €1.2B+ AUM across 35+ funds with offices in San Sebastián, Barcelona, and Madrid to support founders from seed through public listings.
Investment Thesis
Inveready is a multi-strategy alternative asset manager deploying capital across technology venture, life sciences, venture debt, and public equity. They invest in Spanish and European companies throughout their lifecycle from seed to mature stages, with specialized vehicles for each asset class. The firm differentiates itself through 360º financing solutions, deep Spanish ecosystem coverage, and the highest-return alternative asset platform in the Spanish market.
Manager's Experience
Founded by Josep M. Echarri and partners, Inveready’s team combines venture and private equity expertise, investing across multiple asset classes with strong experience in scaling technology and healthcare companies.
Team
Josep Maria Echarri - Founding Partner
Roger Piqué - Founding Partner
Ignacio Fonts - Managing Director
Sarah Bel - Partner Biotech
Portfolio
Feedzai
Gigas
Oncovision
Atlas Molecular Pharma
Pharmacelera
Hospital Capilar
Grupo Uvesco
Reveni
Geniova
Caplena
Wikifarmer
3Scale
Alda Hotels
Schaman
Scaleup Finance
Nanoligent
Medibiofarma